Featured Research

from universities, journals, and other organizations

Development of new corneal cell line provides powerful tool

Date:
December 27, 2012
Source:
Massachusetts Eye and Ear Infirmary
Summary:
Scientists have developed of HCENC-21 and HCEnC-21T, two novel model systems for human corneal endothelium.

Human corneal endothelial cells (HCEnCs) form a monolayer of hexagonal cells whose main function is to maintain corneal clarity by regulating corneal hydration. Cell loss due to aging or corneal endothelial disorders, such as Fuchs dystrophy, can lead to cornea edema and blindness, resulting in the need for cornea transplants.

Related Articles


Studying human corneal endothelium has been difficult for cell biologists because limited cellular model systems exist and have significant drawbacks. The major drawback is that HCEnC cells do not divide and there is a limited source of these cells both for patient transplantation and for study in the laboratory. This field of study is now easier.

Scientists from the Schepens Eye Research Institute, Mass. Eye and Ear, have developed of HCENC-21 and HCEnC-21T, two novel model systems for human corneal endothelium. Their findings, "Telomerase Immortalization of Human Corneal Endothelial Cells Yield Functional Hexagonal Monolayers," are online in the PLOS ONE.

A research team led by Ula Jurkunas, M.D., developed first-of their kind model systems for human corneal endothelium.

"These models mimic very well the critical characteristics and functionalities known from the tissue in the eye," Dr. Jurkunas said. "They also fulfill essential technical requirements, e.g. indefinite number of and a high rate of cell division, to be a powerful tool. They will enable cell biologists to more reliably study human corneal endothelium in health and disease. The ability to enhance HCEnC cell self renewal and growth opens a new window of development of novel regenerative therapies for corneal swelling, hopefully reducing the need for corneal transplantation in the future."


Story Source:

The above story is based on materials provided by Massachusetts Eye and Ear Infirmary. Note: Materials may be edited for content and length.


Journal Reference:

  1. Thore Schmedt, Yuming Chen, Tracy T. Nguyen, Shimin Li, Joseph A. Bonanno, Ula V. Jurkunas. Telomerase Immortalization of Human Corneal Endothelial Cells Yields Functional Hexagonal Monolayers. PLoS ONE, 2012; 7 (12): e51427 DOI: 10.1371/journal.pone.0051427

Cite This Page:

Massachusetts Eye and Ear Infirmary. "Development of new corneal cell line provides powerful tool." ScienceDaily. ScienceDaily, 27 December 2012. <www.sciencedaily.com/releases/2012/12/121227110755.htm>.
Massachusetts Eye and Ear Infirmary. (2012, December 27). Development of new corneal cell line provides powerful tool. ScienceDaily. Retrieved March 2, 2015 from www.sciencedaily.com/releases/2012/12/121227110755.htm
Massachusetts Eye and Ear Infirmary. "Development of new corneal cell line provides powerful tool." ScienceDaily. www.sciencedaily.com/releases/2012/12/121227110755.htm (accessed March 2, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, March 2, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Treadmill Test Can Predict Chance Of Death Within A Decade

Treadmill Test Can Predict Chance Of Death Within A Decade

Newsy (Mar. 2, 2015) Johns Hopkins researchers analyzed 58,000 heart stress tests to come up with a formula that predicts a person&apos;s chances of dying in the next decade. Video provided by Newsy
Powered by NewsLook.com
Going Gluten-Free Could Get You A Tax Break

Going Gluten-Free Could Get You A Tax Break

Newsy (Mar. 2, 2015) If a doctor advises you to remove gluten from your diet, you could get a tax deduction on the amount you spend on gluten-free foods. Video provided by Newsy
Powered by NewsLook.com
GlaxoSmithKline and Novartis Try Swapping Success

GlaxoSmithKline and Novartis Try Swapping Success

Reuters - Business Video Online (Mar. 2, 2015) GlaxoSmithKline and Novartis have completed a series of asset swaps worth more than $20 billion. As Grace Pascoe reports they say the deal will reshape both drugmakers. Video provided by Reuters
Powered by NewsLook.com
How Can West Africa Rebuild After Ebola?

How Can West Africa Rebuild After Ebola?

Reuters - Business Video Online (Mar. 2, 2015) How best to rebuild the three West African countries struggling with Ebola will be discussed in Brussels this week. As Hayley Platt reports Sierra Leone has the toughest job ahead - its once thriving economy has been ravaged by the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins